Table 2 CMR characteristics of control vs. rTOF patients
|  | Healthy Controls (N = 58) | rTOF (N = 167) | P value |
|---|---|---|---|
CMR conventional ventricular parameters | |||
 LVEDVI (ml/m2) | 84.6 (81.0–88.2) | 67.2 (64.1–70.3) |  < 0.001 |
 LVESVI (ml/m2) | 33.3 (31.5–35.1) | 27.7 (25.6–29.8) |  < 0.001 |
 LVEF (%) | 60.8 (59.7–62.0) | 59.9 (58.2–61.5) | 0.997 |
 RVEDVI (ml/m2) | 86.3 (82.3–90.4) | 123.8 (116.6–131.0) |  < 0.001 |
 RVESVI (ml/m2) | 36.5 (34.5–38.4) | 66.1 (61.1–71.0) |  < 0.001 |
 RVEF (%) | 57.6 (55.8–59.3) | 48.1 (46.5–49.7) |  < 0.001 |
LA volume and function vs. controls | |||
 Indexed LAmax Vol. (ml/m2) | 36.1 (33.8–38.4) | 30.7 (28.6–32.8) |  < 0.001 |
 Indexed LAmin Vol. (ml/m2) | 13.9 (12.7–15.1) | 15.4 (13.8–16.9) | 0.715 |
 Indexed LA PAC Vol. (ml/m2) | 21.9 (20.1–23.8) | 22.8 (21.0–24.6) | 0.745 |
 Total LA Function (%) | 61.7 (59.8–63.4) | 51.1 (49.3–53.0) |  < 0.001 |
 Passive LA Function (%) | 39.5 (37.2–41.8) | 26.5 (24.7–28.3) |  < 0.001 |
 Active LA Function (%) | 65.9 (64.6–67.2) | 63.1 (61.7–64.5) | 0.0736 |
LV diastology | |||
 PER (ml/s) | 386 (364–409) | 311 (297–325) |  < 0.001 |
 tPER (ms) | 145 (139–152) | 137 (131–144) | 0.174 |
 PER/EDV (s−1) | 2.84 (2.75–2.95) | 3.65 (2.05–5.26) | 0.417 |
 PFR (ml/s) | 427 (403–451) | 297 (281–314) |  < 0.001 |
 tPFR (ms) | 140 (134–146) | 146 (138–154) | 0.778 |
 PFR/EDV (s−1) | 3.18 (3.03–3.33) | 2.69 (2.57–2.80) |  < 0.001 |